Appendiceal Adenocarcinoma is a rare type of cancer that originates in the cells lining the appendix. It is a form of appendiceal cancer, which itself is uncommon, accounting for less than 1% of all gastrointestinal cancers. This cancer typically arises from glandular (mucus-producing) cells in the appendix. Appendiceal Adenocarcinoma is extremely rare, with an estimated incidence of 0.12 cases per 1,000,000 people per year. 

Stage 3C is more advanced within the Stage 3 category, meaning the cancer has spread to the lining of the abdomen (peritoneum) and may involve multiple areas within the abdominal cavity. At this stage, cancer cells are likely found in multiple sites in the abdomen, including lymph nodes and the peritoneum (the lining of the abdominal cavity), but it has not spread to distant organs like the liver or lungs.

Stage 3C Appendiceal Adenocarcinoma is a serious condition, and treatment typically involves a combination of surgery (often to remove the appendix and affected areas), chemotherapy, and in some cases, hyperthermic intraperitoneal chemotherapy (HIPEC), which is chemotherapy delivered directly to the abdominal cavity during surgery.

Given its complexity, treatment often requires a specialized team of oncologists, surgeons, and other healthcare providers.